FDA up­dates Covid-19 clin­i­cal tri­als guid­ance to ad­dress se­ri­ous ad­verse events

The FDA last week up­dat­ed its guid­ance on con­duct­ing clin­i­cal tri­als amid the coro­n­avirus dis­ease pan­dem­ic to ad­dress how and when spon­sors and ap­pli­ca­tion hold­ers …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER